Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "global-CDMO"

41 News Found

Ajinomoto Bio-Pharma receives FDA approval for high potency fill line
Drug Approval | April 22, 2023

Ajinomoto Bio-Pharma receives FDA approval for high potency fill line

Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line


Sirio Pharma successfully completes acquisition of Best Formulations
News | January 10, 2023

Sirio Pharma successfully completes acquisition of Best Formulations

With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care


Stelis Biopharma’s flagship facility receives EIR from USFDA
Drug Approval | September 01, 2022

Stelis Biopharma’s flagship facility receives EIR from USFDA

The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise


PCI Pharma Services announces US $100 million investment in New England
Biotech | May 13, 2022

PCI Pharma Services announces US $100 million investment in New England

Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends


Bora Pharmaceuticals acquires Eden Biologics CDMO assets
Biotech | May 10, 2022

Bora Pharmaceuticals acquires Eden Biologics CDMO assets

Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market


Sumitomo Chemical to build new API and intermediates plant in Japan
News | April 01, 2022

Sumitomo Chemical to build new API and intermediates plant in Japan

The plant is scheduled to come on stream in September 2024


Sanofi moves forward with EUROAPI listing on Euronext Paris
Biotech | March 18, 2022

Sanofi moves forward with EUROAPI listing on Euronext Paris

EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions


HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
Biotech | March 07, 2022

HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO

According to statistics, the global inhalation drug market reached US $ 25 billion in 2020


Lonza to acquire Exosomics service unit in Italy
Biotech | November 03, 2021

Lonza to acquire Exosomics service unit in Italy

Expertise in exosomes isolation and characterization will drive innovation in this field


PCI Pharma Services acquires LSNE for its CDMO business
News | October 13, 2021

PCI Pharma Services acquires LSNE for its CDMO business

Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle